Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil Immunogenicity in Vietnamese Female Sex Workers
NCT04590521Phase 4Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Sep 2022
- Primary completion
- Apr 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of qHPV vaccine in human papillomavirus infection, sponsored by Murdoch Children's Research Institute. Primary endpoints: Neutralising antibody levels to HPV16 at 7 months and Neutralising antibody levels to HPV18 at 7 months. Started Sep 2022; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT04590521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590521.